Related Experiment Video
Updated: Aug 21, 2026

Assessing Bacterial Invasion of Cardiac Cells in Culture and Heart Colonization in Infected Mice Using Listeria monocytogenes
Published on: May 27, 2015
Outcome of Listeria monocytogenes prosthetic valve endocarditis: as bad as it looks?
Jose M De Miguel-Yanes1, Víctor J González-Ramallo, Luis Pastor
1Emergency Department, Hospital General Universitario "Gregorio Marañón", Madrid, Spain. jmdmiguel@i4con.com
Abstract:
In 1998 we presented 1 successfully treated case of Listeria monocytogenes prosthetic valve endocarditis and made a review of all the cases that had been published to date. We carry out an up-to-date review through Pub-Med of every case of Listeria monocytogenes prosthetic valve endocarditis; mortality rate is calculated and data from several clinical and therapeutical variables are collected; Fisher's exact test is used to identify those variables significantly associated with mortality. Four out of 23 patients died in hospital (17%); among all the variables included, only peripheral embolism (p=0.024), onset on a mechanical prosthesis (p=0.035) and having used only 1 antibiotic instead of a combination of drugs (p=0.026) were independently associated with mortality. Although the overall number of cases is too low to draw definite conclusions (n=23), mortality rate is lower than previously believed. Some variables that have traditionally been associated with a poor prognosis for endocarditides are not for the case of Listeria monocytogenes on valvular prostheses. It seems prudent to treat affected patients with a combination of ampicillin -- or vancomycin, if there is a history of beta-lactam allergy and ampicillin desensitization is not possible -- plus an aminoglycoside.
Insights
Listeria monocytogenes prosthetic valve endocarditis has a lower mortality rate than previously thought. Peripheral embolism and mechanical prosthesis onset are linked to mortality, while combination antibiotic therapy is recommended.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Listeria monocytogenes can cause prosthetic valve endocarditis (PVE).
- Previous reviews established baseline understanding of PVE due to this pathogen.
- An updated review is necessary to assess current outcomes and risk factors.
Purpose of the Study:
- To conduct an up-to-date review of Listeria monocytogenes PVE cases.
- To determine the current mortality rate associated with this condition.
- To identify clinical and therapeutic variables associated with mortality.
Main Methods:
- PubMed database search for Listeria monocytogenes PVE cases.
- Calculation of overall mortality rate.
- Fisher's exact test to identify significant variables associated with mortality.
Main Results:
- A total of 23 cases were reviewed.
- The in-hospital mortality rate was 17% (4 out of 23 patients).
- Peripheral embolism, mechanical prosthesis onset, and monotherapy with antibiotics were significantly associated with mortality.
Conclusions:
- The mortality rate for Listeria monocytogenes PVE may be lower than previously reported.
- Traditional poor prognostic factors for endocarditis may not apply to this specific condition.
- Combination antibiotic therapy (e.g., ampicillin or vancomycin plus an aminoglycoside) is recommended.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Bacterial Meningitis II: Pathophysiology

